Calasoothe Ointment
NDC Package 67777-241-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Calasoothe (calamine, menthol, and zinc oxide) ointment is • Adults: When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. This formulation utilizes a ointment delivery system. Marketed by Dynarex Corporation, this product is identified by NDC 67777-241 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
67777-241-02
Package Description
2 BOX in 1 CASE / 144 PACKET in 1 BOX (67777-241-01) / 3.5 g in 1 PACKET
Product Code
67777-241
11-Digit Billing Format
67777024102

Clinical Specifications

Proprietary Name
Calasoothe
Non-Proprietary Name
Calamine, Menthol, And Zinc Oxide
Substance Name
Menthol; Zinc Oxide; Ferric Oxide Red
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
• Adults: When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product. Apply to the affected area up to 6 times daily or after each bowel movement. • Children under 12 years of age: Consult a doctor

Regulatory & Marketing

Labeler Name
Dynarex Corporation
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-29-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (67777-241). Click a package code to view its specific billing and regulatory data.

67777-241-04
36 JAR in 1 CASE / 71 g in 1 JAR (67777-241-03)
67777-241-06
24 TUBE in 1 CASE / 113 g in 1 TUBE (67777-241-05)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67777-241-02 identifies a specific commercial package of 2 box in 1 case / 144 packet in 1 box (67777-241-01) / 3.5 g in 1 packet of Calasoothe, a human over the counter drug labeled by Dynarex Corporation. This ointment is formulated for topical use and contains menthol; zinc oxide; ferric oxide red as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dynarex Corporation on June 29, 2026. The current certification is valid through December 31, 2027.

How is this Dynarex Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67777024102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67777-241-02
11-Digit CMS (5-4-2)
67777-0241-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.